You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Mycobacterium Infections

Showing 101 - 125 of 7,571
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Innate Immunity, Bacille Calmette-Guérin Trial in Bissau (Bacille Calmette-Guerin, BCG solvent)

Completed
  • Innate Immunity
  • Bacille Calmette-Guérin
  • Bacille Calmette-Guerin
  • BCG solvent
  • Bissau, Bissau Codex, Guinea-Bissau
    Bandim Health Project
Apr 22, 2021

HIV, Tuberculosis Trial in United States (Isoniazid, Pyridoxine HCl)

Completed
  • HIV Infections
  • Tuberculosis
  • Los Angeles, California
  • +13 more
Oct 27, 2021

Hypervirulent and Multi-drug Resistant Pathogens

Recruiting
  • Multiresistant Bacterial Pathogens
  • Virulent Bacterial Pathogens
  • Analysis of Bacterial Genome
  • Basel, Switzerland
  • +4 more
Dec 15, 2021

COVID-19 Trial in Netherlands (BCG Vaccine, Placebo)

Completed
  • COVID-19
  • BCG Vaccine
  • Placebo
  • Den Bosch, Brabant, Netherlands
  • +8 more
Jun 2, 2022

HIV, Tuberculosis Trial in United States (Cycloserine, Ethionamide, Capreomycin sulfate)

Completed
  • HIV Infections
  • Tuberculosis
  • Chicago, Illinois
  • +20 more
Oct 27, 2021

Mycobacterium Avium Complex Pulmonary Disease Trial in Seoul

Not yet recruiting
  • Mycobacterium Avium Complex Pulmonary Disease
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Jun 7, 2023

    Infections, Quality of Life Trial in Columbia (Showering 48 hours after surgery)

    Recruiting
    • Infections
    • Quality of Life
    • Showering 48 hours after surgery
    • Columbia, Missouri
      University of Missouri
    Apr 26, 2023

    Pulmonology Trial in Taipei (Rifamycin-containing regimen, Rifamycin-free regimen)

    Recruiting
    • Pulmonology
    • Rifamycin-containing regimen
    • Rifamycin-free regimen
    • Taipei, Taiwan
      National Taiwan University Hospital
    Oct 18, 2022

    Tuberculosis Trial in Worldwide (FLOW-TB Next-generation LAM, TAM-TB, Host Response Cartridge)

    Recruiting
    • Tuberculosis
    • FLOW-TB Next-generation LAM
    • +13 more
    • Vellore, India
    • +10 more
    Dec 8, 2022

    HIV, Tuberculosis Trial in Puerto Rico, United States (Isoniazid, Pyrazinamide, Pyridoxine HCl)

    Completed
    • HIV Infections
    • Tuberculosis
    • Birmingham, Alabama
    • +75 more
    Oct 26, 2021

    Tuberculosis Infection, HIV Trial in Zomba (CAD4TB, FujiLAM)

    Completed
    • Tuberculosis Infection
    • HIV Infections
    • CAD4TB
    • FujiLAM
    • Zomba, Malawi
      Zomba Central Hospital
    Jan 23, 2023

    Methods in People Living With Retroviral Infection in Liberia

    Active, not recruiting
    • Tuberculosis
    • HIV
      • Bethesda, Maryland
      • +4 more
      Jan 14, 2023

      Triage UltraSound in Tb Endemic Regions

      Recruiting
      • Tuberculosis
      • +2 more
      • POCUS
      • Cotonou, Atlantic, Benin
      • +2 more
      Jun 15, 2022

      Tuberculosis, Latent Tuberculosis Infection Trial in Bijie, Linping, Qingzhen (QuantiFERON-TB Gold (QFT) test)

      Recruiting
      • Tuberculosis
      • Latent Tuberculosis Infection
      • QuantiFERON-TB Gold (QFT) test
      • Bijie, Guizhou, China
      • +4 more
      Sep 12, 2023

      High Risk Myeloid Malignancies, Cord Blood Transplant Trial in New York (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

      Recruiting
      • High Risk Myeloid Malignancies
      • Cord Blood Transplant
      • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 12, 2022

      Tuberculous Meningitis, HIV I Infection Trial in Rio De Janeiro, Maputo, Lusaka (Adalimumab Injection)

      Not yet recruiting
      • Tuberculous Meningitis
      • HIV I Infection
      • Adalimumab Injection
      • Rio De Janeiro, Brazil
      • +2 more
      Jan 31, 2023

      Tuberculosis, Pulmonary Trial (Sitafloxacin, SMZ/TMP, Rifampin)

      Not yet recruiting
      • Tuberculosis, Pulmonary
      • (no location specified)
      Jul 7, 2022

      Healthy Trial in Pretoria (H107e, CAF®10b, H107e/CAF®10b - low adjuvant dose)

      Not yet recruiting
      • Healthy
      • H107e
      • +10 more
      • Pretoria, Gauteng, South Africa
        Aurum Institute
      Sep 24, 2023

      Vitamin D3, Chronic-granulomatous Disease, BCG Trial in Shanghai (Vitamin D3, Traditional treatment of CGD and TB)

      Recruiting
      • Vitamin D3
      • +2 more
      • Vitamin D3
      • Traditional treatment of CGD and TB
      • Shanghai, Shanghai, China
      • +1 more
      Mar 21, 2022

      Host Blood RNA Signatures for Diagnosis of TB (RADIANT)

      Recruiting
      • Tuberculosis
      • NanoString nCounter assay
      • Cape Town, Western Cape, South Africa
      • +1 more
      Sep 12, 2022

      Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

      Not yet recruiting
      • Cutaneous Warts
      • Hepatitis B Virus Vaccine(HBV)
      • (no location specified)
      Jun 13, 2023

      Respiratory Tract Infections, Corona Virus Infection Trial in Vancouver (Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for

      Terminated
      • Respiratory Tract Infections
      • Corona Virus Infection
      • Nitric Oxide 0.5 % / Nitrogen 99.5 % Gas for Inhalation
      • Vancouver, British Columbia, Canada
        Nitric Solutions-Mobile Unit
      Jul 12, 2021

      HIV Transmission in Era of Scaling up Antiretroviral Therapy in

      Recruiting
      • HIV-1-infection
      • Antiretroviral Therapy
      • Exposure to antiretroviral therapy
      • Ādama, Oromia, Ethiopia
        Public hospitals and health centers in the Adama uptake area
      Dec 15, 2022

      HIV Trial in Puerto Rico, United States (Zidovudine)

      Completed
      • HIV Infections
      • Downey, California
      • +50 more
      Oct 28, 2021

      Start Taking Action For TB Diagnosis

      Not yet recruiting
      • Diagnosis
      • Tuberculosis
      • Molecular Diagnostics
      • +4 more
      • (no location specified)
      Apr 25, 2023